title: [Gingival hyperplasia associated with amlodipine].
abstract: Drug-induced gingival hyperplasia is a well documented unwanted side effect within the literature. It has been associated with the use of three different types of pharmaceutical agents, including phenytoin, cyclosporine and calcium channel blocking agents. Amlodipine belongs to the dihydropyridine-derived calcium blocking agents that may cause the side effect of drug-induced gingival hyperplasia. In the present study the possible pathogenic mechanisms, clinical and histologic presentation and therapeutic indications of amlodipine-induced gingival hyperplasia are discussed.
authors.affiliation: Servicio de Cirugía Maxilo Facial y Estomatología, Hospital Universitario Virgen del Rocío, Sevilla.
authors.forename: P
authors.initials: P
authors.lastname: Infante Cossío
authors.forename: J
authors.initials: J
authors.lastname: Torelló Iserte
authors.forename: F
authors.initials: F
authors.lastname: Espín Gálvez
authors.forename: A
authors.initials: A
authors.lastname: García-Perla
authors.forename: L
authors.initials: L
authors.lastname: Rodríguez-Armijo Sánchez
authors.forename: J R
authors.initials: JR
authors.lastname: Castillo Ferrando
mesh_terms: D000368:Aged; D017311:Amlodipine / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced*; D006801:Humans
chemical_list: D002121:Calcium Channel Blockers; D017311:Amlodipine